Companion Diagnostics - Global Market Outlook (2015-2022)

Deerfield Beach, FL -- (SBWire) -- 07/26/2016 --Global [Companion Diagnostics] is estimated $2.62 billion in 2015.
Global [Companion Diagnostics] is growing at a CAGR of 19.78% During forecast period 2015 to 2022.

Global [Companion Diagnostics] is expected to reach value $9.27 billion till year 2022.

Do Inquiry Before Purchasing Report Here: http://www.marketresearchstore.com/report/companion-diagnostics-global-market-outlook-56198#InquiryForBuying

Report Segmented based on: Technologies, Applications, Indications, End User's, Regions.

Global [Companion Diagnostics] geographically segmented into: North America, Europe, Asia Pacific, Rest of the World.

North America represented the largest market for companion diagnostics, followed by the Europe.

Key players in [Companion Diagnostics] are Roche Diagnostics, Quest Diagnostics Inc.Qiagen N.V., Celera, Biomerieux Sa, Abbott Laboratories, Thermo Fisher Scientific, Inc., Labcorp, Genomic Health Inc., Dako (Agilent Technologies), Danaher Corporation, GE Healthcare, Biogenex Laboratories, Siemens and AstraZeneca.

Request For Free Report Sample Here: http://www.marketresearchstore.com/report/companion-diagnostics-global-market-outlook-56198#RequestSample

What our report offers:
- Companion Diagnostics share assessments for the regional as well as country level segments

- Companion Diagnostics share analysis of the top industry players

- Companion Diagnostics report also recommendations for the new entrants

- Companion Diagnostics forecasts for a minimum of 8 years of all the mentioned segments

- Companion Diagnostics Forecasts for sub segments and the regional markets

- Companion Diagnostics Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)

- Report on Companion Diagnostics also recommended key business segments based on the Companion Diagnostics estimations

- Competitive landscaping mapping the key common Companion Diagnostics trends

- Company profiling with detailed Companion Diagnostics strategies, financials, and recent developments

- Supply chain trends mapping the latest technological advancements